Exane Derivatives’s ProShares Trust UltraShort Lehman 20+ Year Treasury TBT Stock Holding History
Bought
Maintained
Sold
Other funds holding TBT
KCM
AAP
KIA
SIM
CM
Exane Derivatives's TBT Position: Q1 2022 in Review
Exane Derivatives sold out of ProShares Trust UltraShort Lehman 20+ Year Treasury (TBT) in Q1 2022, closing a stake of 16,500 shares — an estimated $279K sold.
Exane Derivatives first reported a position in TBT in Q4 2014 and held it in 11 quarters. The position peaked at $1.34M in Q1 2016. 108 funds tracked by Wall St. Rank hold TBT as of Q1 2022.
- Exane Derivatives reported no remaining ProShares Trust UltraShort Lehman 20+ Year Treasury position as of Q1 2022 after selling out during the quarter.
- Exane Derivatives sold 16,500 ProShares Trust UltraShort Lehman 20+ Year Treasury shares in Q1 2022, an estimated $279K.
- Exane Derivatives first reported a position in ProShares Trust UltraShort Lehman 20+ Year Treasury in Q4 2014 and held it in 11 quarters.
- Exane Derivatives's ProShares Trust UltraShort Lehman 20+ Year Treasury position peaked at $1.34M in Q1 2016.
- 108 funds tracked by Wall St. Rank held ProShares Trust UltraShort Lehman 20+ Year Treasury as of Q1 2022.
Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.